BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10738311)

  • 21. Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.
    Wu G; Guo Z; Chatterjee A; Huang X; Rubin E; Wu F; Mambo E; Chang X; Osada M; Sook Kim M; Moon C; Califano JA; Ratovitski EA; Gollin SM; Sukumar S; Sidransky D; Trink B
    Cancer Res; 2006 Oct; 66(20):9829-36. PubMed ID: 17047043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
    Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
    Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Garcia MJ; Pole JC; Chin SF; Teschendorff A; Naderi A; Ozdag H; Vias M; Kranjac T; Subkhankulova T; Paish C; Ellis I; Brenton JD; Edwards PA; Caldas C
    Oncogene; 2005 Aug; 24(33):5235-45. PubMed ID: 15897872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
    Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
    Br J Cancer; 2006 Nov; 95(10):1439-47. PubMed ID: 17060936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines.
    Zhang SY; Liu SC; Johnson DG; Klein-Szanto AJ
    Cancer Res; 2000 Nov; 60(21):5972-6. PubMed ID: 11085515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.
    Alarmo EL; Rauta J; Kauraniemi P; Karhu R; Kuukasjärvi T; Kallioniemi A
    Genes Chromosomes Cancer; 2006 Apr; 45(4):411-9. PubMed ID: 16419056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
    Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
    Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
    Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent amplifications and deletions of G1/S-phase transition genes, CCND1 and MYC in early breast cancers: a potential role in G1/S escape.
    Jensen LB; Bartlett JM; Witton CJ; Kirkegaard T; Brown S; Müller S; Campbell F; Cooke TG; Nielsen KV
    Cancer Biomark; 2009; 5(1):41-9. PubMed ID: 19242061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel gene, GASC1, within an amplicon at 9p23-24 frequently detected in esophageal cancer cell lines.
    Yang ZQ; Imoto I; Fukuda Y; Pimkhaokham A; Shimada Y; Imamura M; Sugano S; Nakamura Y; Inazawa J
    Cancer Res; 2000 Sep; 60(17):4735-9. PubMed ID: 10987278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MYC amplification and TERT expression in breast tumor progression.
    Bodvarsdóttir SK; Steinarsdóttir M; Hilmarsdóttir H; Jónasson JG; Eyfjörd JE
    Cancer Genet Cytogenet; 2007 Jul; 176(2):93-9. PubMed ID: 17656250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression phenotypic models that predict the activity of oncogenic pathways.
    Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR
    Nat Genet; 2003 Jun; 34(2):226-30. PubMed ID: 12754511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.
    Yamamoto F; Yamamoto M
    Electrophoresis; 2007 Jun; 28(12):1882-95. PubMed ID: 17523142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
    Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
    Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.